Stabilization & Maintenance

Moms in Recovery is a program for pregnant and parenting women who struggle with substance use, and form close relationships with counselors, psychiatrists, midwives, pediatricians, case managers and recovery coaches.

MaineMOM aims to improve care for pregnant and postpartum people with opioid use disorder and their infants by integrating maternal and substance use treatment services.

This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.

A new webinar series from the National Academy of Medicine (NAM) and the American Society of Addiction Medicine (ASAM) providing insight and targeted guidance on how to ensure that people with addiction are cared for and protected during the COVID-19 public health crisis.

Outlines how CMS pays Opioid Treatment Programs (OTPs) through bundled payments for opioid use disorder (OUD) treatment services in an episode of care provided to people with Medical Insurance.

Learn how your Opioid Treatment Program (OTP) can become accredited and certified to treat substance use disorders.

Learn how to become a buprenorphine waivered practitioner to treat opioid use disorder (OUD).

This Clinical Practice Guideline (CPG) provides an evidence-based framework for evaluating, treating, and managing the individual needs of patients with substance use disorders (SUD), including alcohol use disorder, in the VA and DoD. It is intended for use by all VA and DoD healthcare providers.